No Data
Earnings Preview: APLS to Report Financial Results Pre-market on February 28
Apellis Pharmaceuticals to Present at the TD Cowen 45th Annual Health Care Conference
Apellis Pharmaceuticals, Inc. (APLS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Is Apellis Pharmaceuticals (APLS) One of the Most Oversold Healthcare Stocks to Buy Now?
Express News | Apellis Pharmaceuticals Inc - Potential U.S. Launch of Pegcetacoplan in Second Half of 2025
Apellis and Sobi Announce EMA Validation of Indication Extension Application for Aspaveli (Pegcetacoplan) for C3G and Primary IC-MPGN
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
been hot today but that's getting into buying range for me..... EBS middle size company that got a new CEO last year completely changed things around since for EBS. take a look at who owns EBS and how much together. this small float is trading around 50% since half or more is already bought up by insiders or tutes